Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Aspire Biopharma Holdings, Inc. - Common Stock (NQ:ASBP)

0.5449 -0.6451 (-54.21%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 15, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	5,185,563
Open	0.9300
Bid (Size)	0.5440 (2,900)
Ask (Size)	0.5499 (1,200)
Prev. Close	1.190
Today's Range	0.5200 - 0.9312
52wk Range	0.0462 - 2.450
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

These stocks are moving in today's session ↗

Today 15:00 EDT

Curious to know what's happening on the US markets one hour before the close of the markets on Wednesday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

Here are the top movers in Wednesday's session. ↗

Today 12:30 EDT

Wondering how the US markets performed in the middle of the day on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

Performance

YTD	+298.0%	+298.0%
1 Month	-44.1%	-44.1%
3 Month	+582.8%	+582.8%
6 Month	+59.2%	+59.2%
1 Year	-12.1%	-12.1%

More News

Wednesday's session: gap up and gap down stocks ↗

Today 10:30 EDT

Via Chartmill

These stocks are moving in today's pre-market session ↗

Today 8:30 EDT

Via Chartmill

Aspire Biopharma's Buzz Bomb Caffeine Company Partners with Interwest Brokerage to Accelerate Retail Expansion

Today 8:00 EDT

Via ACCESS Newswire

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗

March 25, 2026

Via Chartmill

Wednesday's session: top gainers and losers ↗

March 25, 2026

Via Chartmill

Aspire Biopharma's Subsidiary Announces Agreement with TruLife Distribution to Drive National Retail Expansion

March 19, 2026

Via ACCESS Newswire

Aspire Biopharma's Subsidiary, Buzz Bomb Caffeine Company, Appoints John Choe as Western Sales Director

March 17, 2026

Via ACCESS Newswire

Aspire Biopharma's Subsidiary to Feature BUZZ BOMB(TM) at The Health & Fitness Show 2026

March 12, 2026

Via ACCESS Newswire

Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack

March 10, 2026

Via ACCESS Newswire

Stay updated with the stocks that are on the move in today's after-hours session. ↗

March 06, 2026

Via Chartmill

Aspire Biopharma Partners with Microsize to Develop Rapid-delivery Sublingual Powder Formulation of Alprazolam for Faster Anxiety Relief

March 03, 2026

Via ACCESS Newswire

Aspire Biopharma's Buzz Bomb(TM) Caffeine Company Achieves Record Social Media Growth and Sales Surge Following World-Record Marathon Sponsorship

February 25, 2026

Via ACCESS Newswire

Aspire Biopharma Regains Full Compliance with Nasdaq Listing Requirements

February 20, 2026

Via ACCESS Newswire

Aspire Biopharma's Buzz Bomb Caffeine Company Names ChicExecs as Public Relations Agency of Record

February 19, 2026

Via ACCESS Newswire

Aspire Biopharma Files Provisional Patent Application for a Fast-Acting Sublingual Powder Formulation of Meclizine (Generic Dramamine(R))

February 17, 2026

Via ACCESS Newswire

Aspire Biopharma Announces the Appointment of New Member to Its Board of Directors

February 13, 2026

Via ACCESS Newswire

Aspire Biopharma Files Provisional Patent Application for a Fast-Acting Sublingual Powder Formulation of Ondansetron (Generic Zofran(R))

February 12, 2026

Via ACCESS Newswire

Aspire Biopharma Announces $21 Million Private Placement by Select Investors, Strengthening Balance Sheet, Capital Position, and Fortifying Shareholder Equity to Meet Nasdaq Requirements

February 11, 2026

Via ACCESS Newswire

Aspire Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement

February 10, 2026

Via ACCESS Newswire

Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, to Showcase BUZZ BOMB(TM) Caffeine and its Innovative Sublingual Delivery Technology at The Sports & Active Nutrition Summit

February 05, 2026

Via ACCESS Newswire

Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, Partners with Blue Shark Beverages to Expand Southern California Distribution

February 03, 2026

Via ACCESS Newswire

Let's take a look at the stocks that are in motion in today's session. ↗

January 30, 2026

Via Chartmill

Aspire Biopharma Scales Consumer Division with Delivery of Two Million BUZZ BOMB(TM) Units Featuring Modernized Brand Identity

January 22, 2026

Via ACCESS Newswire

Frequently Asked Questions

Is Aspire Biopharma Holdings, Inc. - Common Stock publicly traded?

Yes, Aspire Biopharma Holdings, Inc. - Common Stock is publicly traded.

What exchange does Aspire Biopharma Holdings, Inc. - Common Stock trade on?

Aspire Biopharma Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Aspire Biopharma Holdings, Inc. - Common Stock?

The ticker symbol for Aspire Biopharma Holdings, Inc. - Common Stock is ASBP on the Nasdaq Stock Market

What is the current price of Aspire Biopharma Holdings, Inc. - Common Stock?

The current price of Aspire Biopharma Holdings, Inc. - Common Stock is 0.5449

When was Aspire Biopharma Holdings, Inc. - Common Stock last traded?

The last trade of Aspire Biopharma Holdings, Inc. - Common Stock was at 04/15/26 04:00 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.